Remove Invention Remove Litigation Remove Marketing Remove Patent Prosecution
article thumbnail

Keeping up with Belgian patent litigation: Year case law review 2021

The IPKat

The winds of a busy Belgian court term blows through the IPKat's wild ancestor's mane (c) Christopher Stothers 'Tis the season for a look at the cases that were in 2021 from around Europe and what they mean for the IP litigation themes in those jurisdictions now that the dust has settled in 2022. The decisions we (arbitrarily!)

article thumbnail

Fish & Richardson Attorneys Megan Chacon and Crystal Culhane Named 2021 Women of Influence in Law by the San Diego Business Journal

Fish & Richardson Trademark & Copyright Thoughts

Megan Chacon focuses her practice on complex patent litigation across a wide range of technologies. She currently represents Gilead Sciences, one of the largest and most well-known biotechnology companies in the world, in multiple patent litigation matters. Crystal Culhane draws upon her Ph.D.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

USPTO Requests Input on Patent Eligibility from Critical Sectors Impacted by Current Law

The IP Law Blog

Step 2: If the claims are directed to an abstract idea, then the court determines whether the claims include elements showing an inventive concept that transforms the idea into a patent-eligible invention. Patent attorneys and inventors are often left to guess whether a particular invention is patent-eligible.

Law 109
article thumbnail

It is Time to Tell Your Eligibility Stories

Patently-O

This includes patent prosecution, enforcement, R&D, employment, innovation, sales, competition, etc. How is eligibility jurisprudence impacting the following: quantum computing; AI; precision medicine; diagnostic methods; pharmaceutical treatments; and other computer-related inventions?

article thumbnail

HOW INTELLECTUAL PROPERTY LAW CAN SOLVE LITIGATION SURROUNDING THE HATCH-WAXMAN ACT BROUGHT BY THE COURT’S DECISION IN BRAEBURN V. FOOD & DRUG ADMINISTRATION

JIPL Online

This Blog aims to examine the Hatch-Waxman Act and one of the most significant incentives behind it, a three-year market exclusivity period for the “new clinical investigations.” iv] If deemed insignificant, the new drug is blocked from entering the market by the existing drug’s three-year market exclusivity. [v] products.” [xix]

article thumbnail

EPO Decisions – The Not So Holy Grail?

SpicyIP

Image from here Issues related to patent quality are pressing and worrying, even a standard measure of monitoring patent quality has been difficult. Of late, even in the EU, there has been an increased focus on the quality of patents in response to the rise of business models centered around patent litigation.

article thumbnail

Fish Attorneys Named Finalists for San Diego Business Journal “Leaders in Law” Award

Fish & Richardson Trademark & Copyright Thoughts

In addition to his litigation work, Amon serves as vice managing principal and pro bono coordinator of Fish’s San Diego office. has established herself as a go-to attorney for pharmaceutical, chemistry, biotechnology, and nanotechnology clients who depend on her to help bring their life-saving drugs and inventions to market.